Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG:

sudocetaxel zendusortide (TH 1902)

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Company:

Theratechnologies

Drug class:

Tubulin polymerization promoter, Microtubule stabilizer, Sortilin inhibitor

Related drugs:

SORT1 positive	Solid Tumor	SORT1 positive	Solid Tumor	TH 1902 Sensitive: B - Late Trials TH 1902 Sensitive : B	TH 1902 Sensitive: B - Late Trials TH 1902 Sensitive : B
SORT1 expression	Melanoma	SORT1 expression	Melanoma	TH 1902 Sensitive: C2 – Inclusion Criteria TH 1902 Sensitive : C2	TH 1902 Sensitive: C2 – Inclusion Criteria TH 1902 Sensitive : C2
SORT1 expression	Triple Negative Breast Cancer	SORT1 expression	Triple Negative Breast Cancer	TH 1902 Sensitive: C2 – Inclusion Criteria TH 1902 Sensitive : C2	TH 1902 Sensitive: C2 – Inclusion Criteria TH 1902 Sensitive : C2
SORT1 expression	Ovarian Cancer	SORT1 expression	Ovarian Cancer	TH 1902 Sensitive: C2 – Inclusion Criteria TH 1902 Sensitive : C2	TH 1902 Sensitive: C2 – Inclusion Criteria TH 1902 Sensitive : C2
SORT1 expression	Pancreatic Cancer	SORT1 expression	Pancreatic Cancer	TH 1902 Sensitive: D – Preclinical TH 1902 Sensitive : D	TH 1902 Sensitive: D – Preclinical TH 1902 Sensitive : D
SORT1 expression	Colorectal Cancer	SORT1 expression	Colorectal Cancer	TH 1902 Sensitive: D – Preclinical TH 1902 Sensitive : D	TH 1902 Sensitive: D – Preclinical TH 1902 Sensitive : D
SORT1 positive	Triple Negative Breast Cancer	SORT1 positive	Triple Negative Breast Cancer	TH 1902 Sensitive: D – Preclinical TH 1902 Sensitive : D	TH 1902 Sensitive: D – Preclinical TH 1902 Sensitive : D
HER-2 positive	HER2 Positive Breast Cancer	HER-2 positive	HER2 Positive Breast Cancer	TH 1902 Sensitive: D – Preclinical TH 1902 Sensitive : D	TH 1902 Sensitive: D – Preclinical TH 1902 Sensitive : D